Abeona Therapeutics Inc Warrant
ABEOW
ABEOW was delisted on the 20th of December, 2019.
3 hedge funds and large institutions have $17.3M invested in Abeona Therapeutics Inc Warrant in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
8% less capital invested
Capital invested by funds: $18.9M → $17.3M (-$1.51M)
25% less funds holding
Funds holding: 4 → 3 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $14.6M | – | – | – |
|
|
HCM
2
Highbridge Capital Management
New York
| $2.73M | – | – | – |
|
3
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$1K | -100 | Closed |
|
ABEOW Hedge Fund Activity: Q4 2017 in Review
3 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q4 2017, worth a combined $17.3M — down 8% from $18.9M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ABEOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $1K sold.
- 3 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q4 2017, down from 4 in Q3 2017.
- Funds reported $17.3M of Abeona Therapeutics Inc Warrant stock for Q4 2017, down 8% quarter-over-quarter.
- 0 funds opened new Abeona Therapeutics Inc Warrant positions in Q4 2017 and 1 closed out, a net change of -1 holder.
- The largest Abeona Therapeutics Inc Warrant seller in Q4 2017 was UBS Group, an estimated $1K sold.
Based on aggregated 13F filings for Q4 2017.